Research Article

A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis

Figure 4

The prediction accuracy and prognostic value of m5CPS in IPF. (a) The accuracy of m5CPS in predicting the one-, three-, and five-year survival of IPF patients. (b) The accuracy of m5CPS and single genes in predicting the one-year survival of IPF patients. (c) Heatmaps of the expression profile of m5CPS and clinical characteristics in the training, test, and validation cohorts. GAP: gender-age-physiologic variables. , , and . (d) Risk plots of the training, test, and validation cohorts.
(a)
(b)
(c)
(d)